Year: 2024

Mullen Subsidiary, Bollinger Motors, Delivers B4 Trucks to West Coast Dealer, TEC Equipment

Written by Customer Service on October 30, 2024. Posted in Public Companies.

Bollinger Motors receives payment via electronic transfer with immediate revenue recognition in current fiscal quarter ending December 2024TEC Equipment is a family-owned, full-service truck and trailer dealership group with more than 30 locations across eight statesThe first saleable units of the Bollinger B4, Class 4 all-electric truck rolled off the assembly line in September.BREA, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announced today that its subsidiary, Bollinger Motors (“Bollinger”) has made its first customer delivery on the West Coast, sending three 2025 Bollinger B4 chassis cab electric trucks to TEC Equipment (“TEC”) in Lacey, Washington, Fontana, California, and Oakland, California....

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Written by Customer Service on October 30, 2024. Posted in Public Companies.

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced today that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The listing compliance matter is now closed. Below are some recent key developments in the business. Key HighlightsTop-line results from the Bateman Horne Center’s phase 2a study of IMC-2 for the treatment of Long-COVID are expected to be released in mid-November 2024. Integration efforts continue following the Company’s acquisition of Pharmagesic (Holdings) Inc. in early October 2024.About Dogwood Therapeutics Dogwood Therapeutics (Nasdaq: DWTX) is a development-stage biopharmaceutical company focused on developing...

Warehouse On Wheels Expands Mobile Storage Rental Network with Acquistion in Toronto Canada

Written by Customer Service on October 30, 2024. Posted in Mergers And Acquisitions.

Chicago, Oct. 30, 2024 (GLOBE NEWSWIRE) — Warehouse on Wheels (“WOW”), formerly known as American Trailer Rental Group, a portfolio company of Wind Point Partners (“Wind Point”), and a leading provider of mobile storage solutions is pleased to announce the acquisition of Triton Assets Limited (“Triton”), a Toronto, Ontario-based provider of trailer rental solutions to the manufacturing, distribution, and the entertainment industries.” The Triton acquisition represents another step in WOW’s aggressive growth strategy and capabilities to service customers across the greater Toronto area. The addition of Triton represents WOW’s twenty-second acquisition, alongside eight greenfield expansion locations since partnering with Wind Point. “Triton represents an important addition to WOW that furthers our strategic objective of aggressive...

FINGRID GROUP – MANAGEMENT’S REVIEW 1 JANUARY–30 SEPTEMBER 2024

Written by Customer Service on October 30, 2024. Posted in Earnings Releases And Operating Results.

FINGRID GROUP – MANAGEMENT’S REVIEW 1 JANUARY–30 SEPTEMBER 2024 Fingrid follows a six-month reporting period in compliance with the Securities Markets Act and publishes Management’s Reviews for the first three and nine months of the year; the Management’s Reviews contain key information illustrating the company’s financial and other development. The information presented in the Management’s Review relates to Fingrid Group’s performance in January-September 2024 and the corresponding period of 2023, unless otherwise indicated. The figures presented here have been drawn up in accordance with the International Financial Reporting Standards (IFRS). The Management’s Review is not an interim report in accordance with the IAS 34 standard. The figures are unaudited.The transmission reliability rate of Fingrid’s grid was high, at 99.99930 (99.99996)...

Stack Capital Group Inc. Completes $15.8 Million Main Tranche of a Total $16.7 Million Best Efforts Financing

Written by Customer Service on October 30, 2024. Posted in Public Companies.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) — Stack Capital Group Inc. (“Stack Capital”) (TSX: STCK) is pleased to announce that it has closed the main tranche of its previously announced private placement (the “Offering”) of up to 1,515,908 units (the “Units”) of Stack Capital (including pursuant to the exercise in full of the agents option) for aggregate gross proceeds of up to $16.675 million, priced at $11.00 per Unit. The main tranche consisted of the sale of 1,437,839 Units for gross proceeds of $15,816,229. A second additional tranche has been committed for the balance of the Units that may be issued under the Offering and is expected to close in mid-November 2024. The Offering was conducted on a best efforts basis...

Backblaze and Opti9 Partner to Bring High Performance and Low Cost Cloud Storage to Joint Customers

Written by Customer Service on October 30, 2024. Posted in Public Companies.

Offering Includes New Canadian Data Region for Backblaze and Integrates B2 Cloud Storage with Opti9’s Managed Cloud Services, Security, Backup, and Disaster Recovery Solutions SAN MATEO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) — Backblaze, Inc. (Nasdaq: BLZE), the cloud storage innovator providing a modern alternative to traditional cloud providers, and Opti9, an international leader in hybrid cloud solutions, today announced a partnership to bring the performance of Backblaze B2 Cloud Storage to Opti9’s suite of managed service offerings and solutions. As part of the partnership, Backblaze announced plans to open a new data region in Canada. Opti9 will be the exclusive Canadian channel for Backblaze B2 Reserve and the Powered by Backblaze program. “Backblaze and Opti9 focus on empowering businesses with the best cloud solutions...

IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting

Written by Customer Service on October 30, 2024. Posted in Public Companies.

Results from OVATION 2 Study of IMNN-001 to be highlighted in late-breaking acceptance Company also announces FDA End-of-Phase 2 in-person meeting to discuss Phase 3 trial of IMNN-001 Phase 3 trial is expected to begin in Q1 2025 LAWRENCEVILLE, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced the acceptance of a late-breaking presentation featuring new clinical data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of advanced ovarian cancer, at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting, being held November 6-10, 2024, in Houston, Texas and virtually. The company also announced plans to hold an End-of-Phase 2 meeting with the U.S. Food and...

Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of Water Guard, Inc. in North Carolina

Written by Customer Service on October 30, 2024. Posted in Public Companies.

ROSEVILLE, Minn., Oct. 30, 2024 (GLOBE NEWSWIRE) — Hawkins, Inc. (Nasdaq: HWKN), a leading specialty chemical and ingredients company, has completed the acquisition of the assets of Water Guard, Inc. Water Guard distributes water treatment chemicals and equipment for its customers in Virgina and the Carolinas. “As we continue to grow our water treatment business, Water Guard brings us our first location in North Carolina and helps accelerate our expansion on the East Coast,” said Hawkins Chief Executive Officer Patrick H. Hawkins. “Water Guard has built a strong business that we have admired for years and that is well-connected with the local community. We intend to maintain and expand those connections and look forward to a bright future together.” Jim Moyer, President and Owner of Water Guard, Inc. said, “Water Guard has been...

FE International Advises on the Strategic Acquisition of UX Design Platform by Digital Marketing Services Provider

Written by Customer Service on October 30, 2024. Posted in Mergers And Acquisitions.

NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) — FE International, Inc., the global market leader in middle-market technology mergers and acquisitions (M&A), is pleased to announce the strategic acquisition of a website-user flow design platform by a PE-backed digital services and marketing platform. The platform offers an array of critical services for web developers and user-experience (UX) designers, thousands of customizable interfaces, instructional materials, and related support services. Overall, the human machine interface (HMI) market is projected to reach over $7 billion worldwide by 2026 through both hardware and software spending. UX platforms make it easier for individuals and business owners to understand best practices for user flows and borrow inspiration from established templates. The Acquirer operates in the digital...

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Written by Customer Service on October 30, 2024. Posted in Public Companies.

WALTHAM, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that initial data from its Phase 1C dose escalation of XTX101 (vilastobart) in combination with atezolizumab in patients with advanced solid tumors will be presented in a late-breaker poster session at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting taking place in Houston, Texas, from November 6-10, 2024. Poster presentation details:Title: Phase 1/2 Study of Vilastobart (formerly XTX101), a Tumor-Activated, Fc-enhanced Anti-CTLA-4 Monoclonal Antibody, in Combination with Atezolizumab in Patients with Advanced Solid Tumors Abstract Number: 1455 Presentation Date: Friday,...

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals